hepatitis-b

Documents about hepatitis-b

• The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication#861404ClinicalTrials.gov
• A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV#868599ClinicalTrials.gov
• Linkage to Care and Treatment of Chronic HBV Patients#915144ClinicalTrials.gov
• Dysregulated BCR repertoire and metabolic state of HBsAg-specific B cells in chronic hepatitis B revealed by integrated single-cell analysis.#449979NCBI PubMed Central
• Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine#454060ClinicalTrials.gov
• Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course#481795ClinicalTrials.gov
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV#1046096ClinicalTrials.gov
• Prevalence and risk factors of hepatitis B, hepatitis C, and syphilis among reproductive-age adults in the Tigray region, Northern Ethiopia: a community-based cross-sectional study.#236377NCBI PubMed Central
• Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus#405858HAL (France)
• Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B#424137bioRxiv / medRxiv
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma#454030ClinicalTrials.gov
• Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy#463740ClinicalTrials.gov
• Vorapaxar and aripiprazole suppress hepatitis B virus replication through distinct host signaling pathways#663834bioRxiv / medRxiv
• TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction#908751ClinicalTrials.gov
• Reactivation and Flare of Chronic Hepatitis B: Natural History, Diagnosis, Therapy and Prevention#930377Acta Interna: The Journal of Internal Medicine
• The Effect of Entecavir Consolidation on Post-TDF Treatment Durability#979026ClinicalTrials.gov
• Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B#917734ClinicalTrials.gov
• Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a#1009440ClinicalTrials.gov
• Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly#136403ClinicalTrials.gov
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)#966746ClinicalTrials.gov
• SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus#238317ClinicalTrials.gov
• Roles of pattern recognition receptors in host viral interaction during Hepatitis B virus infection#256225Universiti Putra Malaysia Institutional Repository
• Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas#264880IRIS
• The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.#275637NCBI PubMed Central
• Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants#290827ClinicalTrials.gov
• A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults#446719PubMed Central
• A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance#802419ClinicalTrials.gov
• Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration#841991ClinicalTrials.gov
• Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV#842380ClinicalTrials.gov
• Gut Microbiome in People Living With HIV and HBV#844011ClinicalTrials.gov
• Prospective Cohort of HIV/HBV-coinfected Patients in Europe#844071ClinicalTrials.gov
• Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B#854023ClinicalTrials.gov
• HBV Vaccination in HIV-infected Adults#857999ClinicalTrials.gov
• Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients#870101ClinicalTrials.gov
• Liver Cancer Disparities in American Indian and Alaska Native Persons#871577ClinicalTrials.gov
• Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients#909783ClinicalTrials.gov
• A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B#916427ClinicalTrials.gov
• Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)#994301ClinicalTrials.gov
• Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)#917111ClinicalTrials.gov
• Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules#158030ClinicalTrials.gov
• Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)#287390ClinicalTrials.gov
• Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin#1046504ClinicalTrials.gov
• Forecasting monthly hepatitis B cases in China: a nationwide comparative study based on surveillance data.#335003NCBI PubMed Central
• Seroepidemiology of hepatitis B virus infection among children in Mongolia : Results of a nationwide survey#384180CiNii
• Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment#387302ClinicalTrials.gov
• The immunoecology of occult hepatitis B virus infection: genetic remodeling and the immune-mediated microcosm.#446216NCBI PubMed Central
• Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines#451532ClinicalTrials.gov
• Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.#899098ClinicalTrials.gov
• Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine#195383ClinicalTrials.gov
• Retrovirus Epidemiology Donor Study-II (REDS-II)#851841ClinicalTrials.gov